Discovery is adhering to all pertinent guidance from the CDC and the WHO to keep our clients and employees safe while continuing to provide ethically obtained biospecimens to support COVID-19 diagnostic, vaccine, and therapeutic development studies.

Leveraging our Discovery Partners®, a global network of over 300 clinical sites, Discovery is providing COVID-19 matched biospecimen sets and can work with you to execute custom, prospective COVID-19 biospecimen collections.

Discovery COVID-19 Biospecimen Sets

Positive and Negative COVID-19 biospecimens matched across the following formats:

  • Swabs in media – Nasopharyngeal, Throat
  • Whole Blood
  • Plasma
  • Serum 
  • Sputum
  • Urine
In addition, we have the following Respiratory Virus related specimens and human biofluids available to support your research:
Adenovirus
Bocavirus
Bronchoalveolar lavage (BAL)
Cerebrospinal fluid (CSF)
Endotracheal aspirate (ETA)
Enterovirus
Human metapneumovirus (hMPV)
Influenza A
Influenza A (H3)
Influenza A 2009 H1
Influenza B
Influenza Vaccine
Nasal Swab
Nasopharyngeal Swab
Parainfluenza
Pneumonia
Respiratory Syncytial Virus (RSV)
Respiratory Viral Panel
Rhinovirus
SARS-CoV-2
Sputum
Synovial Fluid
Characterization:
  • Age of Patient
  • Test Date
  • Gender
  • Ethnicity
  • Test Result*
  • Testing Method
  • Can include:
    • Medical Records
    • Clinical Data
Ready to initiate your COVID-19 project?
Contact Us

*Positive or Negative status for SARS-CoV-2 determined via FDA issued EUA Assay Methods including: Abbott, Cepheid, Luminex, Roche, Life Technologies, Thermo, Hologic

Contact us today to initiate your COVID-19 project

Fill out the form below to reserve your biospecimen set or plan your prospective study.